Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2019 Jul 5;38:288. doi: 10.1186/s13046-019-1298-5

Correction to: Calycosin suppresses TGF-β-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells

Qun Wang 1,2,3,4,✉,#, Weijun Lu 1,2, Tao Yin 1,2, Li Lu 2,3,4,5,✉,#
PMCID: PMC6612221  PMID: 31277716

Correction to: J Exp Clin Cancer Res (2019) 38:240

https://doi.org/10.1186/s13046-019-1243-7

In the original publication of this article [1], there is a mistake in Fig. 7. The tags of TGF-beta and calycosin in Western blotting electrophoresis images are reversed.

Fig. 7.

Fig. 7

a After HCT116 cells were treated with calycosin, TGF-β, or calycosin with TGF-β, western blot analysis was used to determine the protein levels of vimentin, Snail, and N-cadherin and the subcellular distribution of β-catenin protein. b After LoVo cells were treated with calycosin, TGF-β, or calycosin with TGF-β, western blot analysis was used to determine the protein levels of vimentin, Snail, and N-cadherin and the subcellular distribution of β-catenin proteins

The corrected Fig. 7 should be:

Contributor Information

Qun Wang, Email: swander@126.com.

Li Lu, Email: luli117@163.com.

Reference

  • 1.Wang Q, et al. Calycosin suppresses TGF-β-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells. J Exp Clin Cancer Res. 2019;38:240. doi: 10.1186/s13046-019-1243-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES